FLT3 and acute myeloid leukemia: Notably, FLT3 has a prominent role in the hematologic malignancies, with one-third of adult acute myeloid leukemia (AML) patients presenting with activating mutations in FLT3, and wild-type FLT3 being found overexpressed in hematologic malignancies.